AmerisourceBergen to acquire PharMEDium Healthcare

US drug wholesaler AmerisourceBergen (NYSE:ABC) has signed a definitive agreement to purchase PharMEDium Healthcare Holdings, a privately-held national provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals in the USA, from Clayton, Dubilier & Rice for $2.575 billion in cash, subject to certain adjustments and on a cash-free, debt-free basis.

The acquisition is expected to be $0.22 to $0.26 accretive to the company’s adjusted earnings per share in fiscal 2016 on a net basis, and is expected to generate approximately $30 million in synergies by fiscal 2018. The transaction is subject to regulatory review and other customary closing conditions, and is expected to close in the first quarter of fiscal 2016, which ends December 31, 2015.

PharMEDium is the premier provider of customized outsourced CSPs that meet specific hospital and physician clinical needs and quality standards in formulations that are not otherwise commercially available. PharMEDium will become a part of AmerisourceBergen Drug Corp.